TY - JOUR AU - Wang, Dong AU - Yang, Xiao-Hong AU - Zhang, Ji-Dong AU - Li, Rui-Bin AU - Jia, Min AU - Cui, Xiao-Ran PY - 2018 DA - 2018/11/29 TI - Compared efficacy of clopidogrel and ticagrelor in treating acute coronary syndrome: a meta-analysis JO - BMC Cardiovascular Disorders SP - 217 VL - 18 IS - 1 AB - Ticagrelor has been acknowledged as a new oral antagonist of P2Y12-adenosine diphosphate receptor, as a strategy with more rapid onset as well as more significant platelet inhibition function in acute coronary syndrome (ACS) patients. The clinical benefit of ticagrelor compared with clopidogrel remains controversial. The current meta-analysis was conducted to better evaluate the role of ticagrelor in comparison of clopidogrel in treating ACS patients. SN - 1471-2261 UR - https://doi.org/10.1186/s12872-018-0948-4 DO - 10.1186/s12872-018-0948-4 ID - Wang2018 ER -